Plerixafor enables the safe, rapid, efficient mobilization of haematopoietic stem cells in sickle cell disease patients after exchange transfusion.
about
Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease.Hematopoietic stem cell mobilization with plerixafor in sickle cell disease.Gene Therapy for HemoglobinopathiesAn Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype
P2860
Plerixafor enables the safe, rapid, efficient mobilization of haematopoietic stem cells in sickle cell disease patients after exchange transfusion.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Plerixafor enables the safe, r ...... ts after exchange transfusion.
@en
Plerixafor enables the safe, r ...... ts after exchange transfusion.
@nl
type
label
Plerixafor enables the safe, r ...... ts after exchange transfusion.
@en
Plerixafor enables the safe, r ...... ts after exchange transfusion.
@nl
prefLabel
Plerixafor enables the safe, r ...... ts after exchange transfusion.
@en
Plerixafor enables the safe, r ...... ts after exchange transfusion.
@nl
P2093
P2860
P50
P1433
P1476
Plerixafor enables the safe, r ...... ts after exchange transfusion.
@en
P2093
Aurélie Gabrion
Aurélie Stanislas
Brigitte Ternaux
Chloé Couzin
Clémence Plantier
Elisa Magrin
François Lefrère
Hanem Sadek
Isabelle André-Schmutz
Jean-Antoine Ribeil
P2860
P304
P356
10.3324/HAEMATOL.2017.184788
P50
P577
2018-02-22T00:00:00Z